Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Acquisition

23 Nov 2006 07:01

London Asia Chinese Private Equity23 November 2006 23 November 2006 London Asia Chinese Private Equity Fund Limited ("LACPEF" or "the Fund") Investment in Carbon Credit Specialist LACPEF, the China focused investment fund, is pleased to announce that it isinvesting £1.9 million for an 10% stake in China CDM Exchange Centre Ltd ("CCEC"or "the Company"). Founded this year, CCEC is a Jersey incorporated company providing brokerage,advisory and research services relating to the reduction of greenhouse gases ("GHGs") in Asia. It works with businesses and projects that generate carboncredits, and assists the project owner to identify buyers for and sell on thosecarbon credits. As well as providing advice to projects which generate carbon credits, CCEC alsoacts as an emissions broker and maintains its own carbon trading portfolio. Itmanages the only on-line platform for environmental commodity transactions inChina. The Company operates within the framework of the Clean Development Mechanism ("CDM") of the Kyoto Protocol, established under the auspices of the UnitedNations Framework Convention on Climate Change. The Protocol commits countriesto reducing their emissions of GHGs by pre-determined amounts or compensate formaintained or higher GHG emissions via emissions trading. The Company carries out its activities through an alliance with a leadingChinese emissions broker, Beijing Changjiang River International Holding ("CRIH"), and provides all the professional services for projects secured by CRIH.Currently, CCEC is working on 26 projects with aggregate annual CO2 emissions ofapproximately 30 million tons. CCEC's services cover strategy development, analysis, verification, legal andaccounting advice, insurance and other professional services. Owing to itsrelationships with leading energy institutions, particularly Chinese powerproducers and Asian buyers of carbon credits, CCEC focuses on identifying buyersfor larger-than-average CDM projects in China and negotiating CER purchaseagreements on behalf of its clients. As the world's second largest emitter of GHGs, China is expected to overtake theUS in GHG emissions by 2025 and become the major player in the global carbonmarket. To date China is the largest CDM seller and the target for many of thecarbon credit funds created in the last 18 months seeking to buy carbon credits. Victor Ng and Simon Littlewood, Executive Directors of the Fund, are beingappointed non-executive directors to the Company. Mr Kang Zheng, Chief Executive of CDM, said: "We plan to list our business onthe UK's PLUS Stock Market in the near future, and welcome the investment by theFund and assistance from London Asia in getting the PLUS listing, which willincrease our exposure internationally among carbon credit purchasers." Simon Littlewood, Executive Director of LACPEF, commented: "The Fund hasinvested in a number of businesses in the environmental sector that potentiallygenerate carbon credits and could benefit from the services CCEC provides,adding value to our existing investments as well as this new investment. Ourinvestee companies involved in renewables have performed well with China NewEnergy, which joined PLUS in September, reporting strong trading yesterday" For further information please visit www.londonasiafunds.com or contact:John West/Matt Ridsdale Simon Littlewood Hugh FieldTavistock Communications London Asia Capital plc Collins Stewart LimitedTel: 020 7920 3150 Tel 020 7355 7928 Tel: 020 7523 8000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.